HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Giorgia Teresa Maniscalco Selected Research
Giorgia Teresa Maniscalco Research Topics
Disease
22
Multiple Sclerosis
09/2022 - 01/2011
6
Relapsing-Remitting Multiple Sclerosis
09/2022 - 01/2015
3
COVID-19
06/2022 - 01/2022
3
Progressive Multifocal Leukoencephalopathy
02/2022 - 01/2020
2
Nervous System Diseases (Neurological Disorders)
07/2022 - 10/2021
2
Infections
06/2022 - 01/2022
2
Neoplasms (Cancer)
10/2021 - 11/2020
2
Epilepsy (Aura)
10/2021 - 11/2020
2
Sudden Infant Death (SID)
05/2021 - 01/2020
1
Glioma (Gliomas)
07/2022
1
Disease Progression
01/2022
1
Cognitive Dysfunction
10/2021
1
Cerebellar Ataxia (Dysmetria)
10/2021
1
Melanoma (Melanoma, Malignant)
10/2021
1
Stiff-Person Syndrome (Stiff Man Syndrome)
10/2021
1
Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
10/2021
1
Encephalitis (Encephalitis, Rasmussen)
04/2021
1
Optic Neuritis (Retrobulbar Neuritis)
04/2021
1
Starvation
01/2021
1
Sarcoma (Soft Tissue Sarcoma)
11/2020
1
Seizures (Absence Seizure)
11/2020
1
Inflammation (Inflammations)
10/2019
1
Overactive Urinary Bladder (Overactive Bladder)
01/2018
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2015
1
Autoimmune Diseases (Autoimmune Disease)
11/2015
Drug/Important Bio-Agent (IBA)
5
Natalizumab (Tysabri)
FDA Link
02/2022 - 01/2011
3
COVID-19 Vaccines
IBA
07/2022 - 01/2022
3
Alemtuzumab (Campath)
FDA Link
01/2022 - 10/2019
3
Dronabinol (THC)
FDA Link
Generic
10/2020 - 01/2018
2
Proteins (Proteins, Gene)
FDA Link
07/2022 - 10/2019
2
Antibodies
IBA
07/2022 - 04/2021
2
Vaccines
IBA
07/2022 - 02/2022
2
mRNA Vaccines
IBA
06/2022 - 02/2022
2
Cannabidiol
IBA
10/2020 - 01/2020
2
nabiximols (Sativex)
IBA
01/2020 - 01/2017
1
Cladribine
FDA Link
Generic
09/2022
1
Antigens
IBA
07/2022
1
Leucine (L-Leucine)
FDA Link
07/2022
1
Glutamate Decarboxylase (Decarboxylase, Glutamate)
IBA
07/2022
1
BNT162 Vaccine
IBA
06/2022
1
Immunoglobulin G (IgG)
IBA
06/2022
1
ocrelizumab
IBA
04/2022
1
Monoclonal Antibodies
IBA
04/2022
1
nitazoxanide (NTZ)
FDA Link
02/2022
1
Interferon beta-1a
FDA Link
02/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Interferon-beta
IBA
01/2022
1
Nivolumab
IBA
10/2021
1
Immune Checkpoint Inhibitors
IBA
10/2021
1
Steroids
IBA
10/2021
1
Intravenous Immunoglobulins (IVIG)
FDA Link
10/2021
1
Influenza Vaccines (Influenza Vaccine)
FDA Link
07/2021
1
Cytidine Diphosphate (CDP)
IBA
01/2021
1
Amino Acid Transport Systems (Amino Acid Transporter)
IBA
01/2021
1
Anticonvulsants (Antiepileptic Drugs)
IBA
11/2020
1
Autoantibodies
IBA
11/2020
1
Pharmaceutical Preparations
IBA
10/2020
1
Glucocorticoids
IBA
10/2019
1
Annexin A1
IBA
10/2019
1
Fingolimod Hydrochloride (FTY720)
FDA Link
10/2019
1
Interferons
IBA
01/2016
1
Interleukin-2 (IL2)
IBA
11/2015
1
Uric Acid (Urate)
IBA
01/2015
Therapy/Procedure
8
Therapeutics
06/2022 - 01/2020
3
Injections
01/2021 - 01/2016
2
Aftercare (After-Treatment)
10/2021 - 04/2021
1
Immunotherapy
11/2020
1
Radiotherapy
11/2020